|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2008-7-31
|
|
pubmed:abstractText |
Systemic and inhalation therapy of granulocyte-macrophage colony-stimulating factor (GM-CSF) is usually effective in controlling autoimmune pulmonary alveolar proteinosis (PAP), but some cases are refractory to GM-CSF therapy and subjected to whole lung lavage (WLL). A 9-year-old girl developed severe respiratory failure due to autoimmune PAP was treated with inhalational 250 microg of GM-CSF daily, however, it was ineffective. Unilateral WLL was performed three times and subsequent GM-CSF inhalation therapy yielded marked physiological and radiological improvement and was continued for 1 year.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1099-0496
|
|
pubmed:author |
pubmed-author:AgataHiroatsuH,
pubmed-author:AwayaTomonariT,
pubmed-author:BabaKenjiK,
pubmed-author:KandatsuNobuhisaN,
pubmed-author:KawaiSeikoS,
pubmed-author:KomatsuToruT,
pubmed-author:NakataKohK,
pubmed-author:NishikomoriRyutaR,
pubmed-author:TsurusawaMasahitoM,
pubmed-author:YamaguchiEtsuroE,
pubmed-author:YamamotoHajimeH
|
|
pubmed:copyrightInfo |
(c) 2008 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
828-30
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis.
|
|
pubmed:affiliation |
Department of Pediatrics, Aichi Medical University School of Medicine, Aichi, Japan.
|
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|
